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A C C E P T E D M A N U S C R I P T
INTRODUCTION
Complex intracranial aneurysms include giant aneurysms (maximum dome size exceeds 25 mm), fusiform or blister morphology, wide-necked aneurysms (dome/neck ratio more than 1.5:1), lesions with side branch originating from the neck or sac, those with a significant thrombus in the lumen and considerable atherosclerotic changes in the neck. [1] It is known that the mortalitymorbidity rate for giant intracranial aneurysms is oscillating around 15-25% [2] , [3] , [4] , [5] Despite improvements in endovascular and microsurgical techniques, treatment of complex intracranial aneurysms remains challenging. Such aneurysms cannot be occluded by direct clipping, and endovascular coiling requires complex assisting techniques.
Hunterian proximal occlusion is a relatively simple technique that has been used in an attempt to divert flow away from the aneurysm and to induce thrombosis. [6] Despite that Hunterian ligation is very effective, though it is not possible to sacrifice artery in all patients. Different bypass A C C E P T E D M A N U S C R I P T techniques are required to prevent ischemic complications in patients with insufficient flow through communicating arteries after ligation. The risk of ischemic complications exists even in patients with negative balloon test occlusion test (BTO). [7] , [8] , [9] , [10] A plenty of series have been published, which proves the efficacy and safety of parent artery occlusion (PAO) with bypass in treatment of complex aneurysms. [9, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Flow diverters have been approved for the treatment of large and giant aneurysms of cavernous carotid. [23] , [24] Indications to diverters is expanding to blister, bifurcation [25] , distal [26] and posterior circulation [27] aneurysms. However, the results of FIAT trial have showed that flow diversion is not as safe and effective as hypothesized with 5.3% rate of morbidity and 10.7% rate of mortality. [28] We performed prospective randomized comparison of clinical and surgical outcomes of flow diversion versus PVO and bypass in patients with complex anterior circulation aneurysms. A total of 111 potential participants were enrolled since March 2015. The protocol of study was approved by Local Ethics Committee and published on clinicaltrials.gov (Identifier NCT03269942). Flow chart of study is presented in Figure 1 .
MATERIALS AND METHODS

Study of complex intracranial aneurysms treatment (SCAT)
Centralized randomization process was provided by sealed envelopes method. 55 patients were randomized into flow diversion group and 56 patients -into PAO with bypass group. After enrollment of patient and comparing baseline characteristics the statistical significant difference between groups was found by age (p=0.03) and neck size (p=0.05). The propensity score with 1-to-1 nearest neighbor caliper matching without replacement was used to minimize accidental
bias for all major clinical and angiographic characteristics (Figure 2 ). Equal groups with 40 patients in each were selected after propensity score matching. The baseline characteristics of patients presented in Table 1 .
Written informed consent was provided by each patient. Patients undergoing FD treatment received double antiplatelet therapy (DAT), with baby aspirin and loading dose of clopidogrel 600 mg once followed by 75 mg daily. We assessed platelet response using light transmission aggregometry (LTA) and VerifyNow System (Accriva Diagnostics, San Diego, California). The clopidogrel non-responders received ticagrelor 90 mg twice a day. We did not perform adjunctive coiling in FD cases.
Bypass patients received baby aspirin for 3 days preoperatively. We did not use anticoagulation drugs after procedure. We did not routinely perform BTO due to high rate of false-negative results [7] , [8] , [9] , [10] . Operations were accompanied with neurophysiologic somatosensoryevoked potentials (SSEP). High-flow shunts were performed using radial artery graft. We routinely evaluated the graft patency using indocyanine green videoangiography (ICG-VA) and ultrasound flowmeter as described by authors. [29, 30] , [31] After 6 and 12 months post-operatively we assessed patient mRS score, cross-sectional and angiographic data. The primary end point was the rate of neurological deterioration. We recorded neurological morbidity when the mRS score increased by more than 1 or mRS ≥ 4 was achieved.
Secondary endpoints included the rates of aneurysm total occlusion, major stroke or neurological death related to the index aneurysm.
The descriptive data are represented as a median (first quantile-third quantile) for non-normal distribution. The categorical and rank data are represented as a number (percentage of total There were 40 bypass procedures in the matched cohort: high-flow bypass (n=20; 50%), doublebarrel bypass (n=7; 17.5%), low flow bypass (n=4; 10%), and in situ bypass (n=9; 22.5%). High flow bypass was performed using radial artery graft in all cases. Trapping was performed in 15 cases (37.5%), proximal ligation -9 cases (22.5%), distal ligation in 1 patient with fusiform M1
aneurysm (2.5%) and in-situ bypass in 14 patients (35%). One bypass procedure has failed. 
SECONDARY OUTCOMES
The rate of complete aneurysm occlusion at 6 months was 42.5% in the FD group and 95% in surgical group (p<0,0001). In one patient with fusiform M1 aneurysm we performed high-flow ECA-M2 bypass with distal ligation. Near-total occlusion was achieved in 1 patient at 6 months, however he met total occlusion at 12 months after discontinuing antiplatelets.
The rate of complete occlusion at 12 months was 65% in the FD group and 97.5% in surgical group. The difference between groups was still significant (p=0.001). In the FD group 8 patients were retreated at follow up due to non-occlusion or intrastent stenosis. Retreatment rate was significantly higher in the FD group (p=0.02).
The rate of total major complications was 22.5% in surgical group (6 ischemic and 3 hemorrhagic events out of 40 patients) and 5% in FD group (1 ischemic and 1 hemorrhagic events out of 40 patients) during follow up period (p=0.048). Early bypass thrombosis occurred in 6 patients (15%). All hemorrhagic complications in surgical group occurred before postoperative day 3.
Despite lower occlusion rates in the FD group, there were no cases of late hemorrhage in this group. The only ischemic complication in this group was perforator infarction.
PREDICTORS OF OUTCOMES
Univariate analysis has demonstrated that partial thrombosis of the index aneurysm is an independent predictor of aneurysm obliteration (OR=0.3, p=0.019) ( Table 2) , while in situ Comparing the results of flow diversion and surgical revascularization, better clinical outcomes after 12 months the FD group were obvious (97.5% compared to 80% mRS favorable outcomes, p=0.014). Despite better clinical results, flow diversion provided total occlusion rate of only 65% at 12 months. We can suggest that this is due to relatively short follow-up in our study and relatively high percentage of the aneurysms with positive non-occlusion risk factors (side branch originating from sac, bifurcation and distal aneurysms). It is known that delayed rupture of aneurysms after FD implantation is estimated as less than 1% [33] .
Intraoperative or early postoperative hemorrhagic complications occurred in 2.5 % and 7.5% in FD and bypass groups respectively. Postoperative ischemic complications occurred in 2.5% and 15% in FD and bypass groups respectively. We evaluated postoperative diffusion weighted images (DWI) to detect clinically silent ischemia. Brasiliense et al [34] reported 62.7% rate of silent ischemic events after PED. Recent meta-analysis [35] demonstrated that FD implantation lead to DWI positive events in 67% of procedures. DSA at 6 months allowed to find clinically silent intrastent stenosis in 7.5%. None of intrastent stenosis led to ischemia. High rate of bypass thrombosis (15%) at 12 months follow up is predominantly related to supraclinoid ICA aneurysms (3 out of 6 aneurysms). Both lethal cases occurred due to early bypass thrombosis, but there was no significant difference between groups in the rate of ischemic events otherwise.
A C C E P T E D M A N U S C R I P T
According to our results, in situ bypass and protective bypass were associated with unfavorable clinical outcomes. Due to technical complexity, in situ bypass is associated with an increased risk of complications. On the other hand, protective bypass was used in knowingly more challenging cases which also could contribute to higher complication rate among these patients.
Additional cause of ischemic complications was prolonged anastomosing time.
Partial thrombosis of giant intracranial aneurysms occurs in up to 60% of such lesions. [36] Despite this finding complicates microsurgical treatment, our study demonstrated that partial thrombosis is an independent factor of complete aneurysm obliteration. Partial thrombosis of index aneurysm is a predictor of non-occlusion in coiled and clipped aneurysms. However, it is not known to be a risk factor of non-occlusion in flow diversion cases. The majority of partially thrombosed aneurysm at baseline were in the bypass group, which may explain the positive predictive role of partial thrombosis in aneurysm occlusion, according to our series.
According to one recent meta-analysis, PVO with extra-to intracranial bypass in cavernous aneurysms resulted in total occlusion of 93% of lesions with morbidity and mortality 11% and 7% respectively [37] Large and giant paraclinoid aneurysms is often associated with cranial neuropathy. According to the literature, the rate of cranial neuropathy regression after flow diversion is comparable to that after microsurgery [40] [41] [42] . Our results are in accordance with previously published experience as 5 of 9 patients (55%) in FD group demonstrated complete resolution of symptoms.
In our microsurgery cohort there was complete resolution of neuropathy in 9 of 16 (56.2%) of patients. We found no significant difference in terms of cranial neuropathy resolution between the groups and thus do not consider this symptom as an absolute indication for microsurgery.
Moreover, all of 5 ophthalmic aneurysms treated by implantation of flow diverter results in 100% obliteration of aneurysm in 12 months without side branch occlusion or any visual disturbances.
The recent studies prove the efficacy and safety of flow diversion in supraclinoid ICA with 82.7% rate of complete aneurysm occlusion and 96.5% patency of anterior choroidal artery. [43] In the microsurgical group, both cases of communicating segment aneurysms were associated
with postoperative ischemic strokes due to early graft thrombosis. We consider it as the most unfavorable location for PVO and bypass. In the FD group the aneurysm total occlusion rate was low (4 out of 9 patients, 44.4%), but there were no ischemic or hemorrhagic complications. There Hence, it's important to stratify patient by the natural risk of aneurysm rupture prior to treatment selection.
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